← Leaderboards
Giulio Taglialatela
University Of Texas Medical Br Galveston
$10,213,504
Attributed
$16,601,293
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,601,293 · 12
By mechanism
R01$10,122,073 · 5
RF1$3,532,750 · 1
R56$1,501,956 · 2
R21$808,799 · 2
R25$421,736 · 1
R29$213,979 · 1
Top collaborators
- Maria-Adelaide Micci7 shared
- Agenor Limon5 shared
- Rakez Kayed2 shared
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Yogesh Chandra Awasthi$6,761,569
- Claudio Soto$38,520,610
- Cary W Cooper$1,666,580
- Andres Fernando Oberhauser$2,807,420
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainMolecularEventNeuropathologyTau ProteinsSynapsesInnovationProteinsAutomobile DrivingResistanceHealth Care CostsMediatingCaringMissionFosteringUnited States National Institutes Of HealthFunctional DisorderAffectCognitiveEffective TherapyBindingAmyloid Beta-Protein
Grant awards (31)
Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders$733,677
R01 · FY2025 · AG · contact PI
Selective vulnerability and resilience to trans-synaptic pathological tau spreading in Alzheimers disease$200,000
R21 · FY2025 · AG · contact PI
Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders$759,259
R01 · FY2024 · AG · contact PI
Promoting Brain Resilience to Alzheimer's Neuropathology$753,382
R01 · FY2024 · AG · contact PI
Selective vulnerability and resilience to trans-synaptic pathological tau spreading in Alzheimers disease$240,000
R21 · FY2024 · AG · contact PI
Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders$769,661
R01 · FY2023 · AG · contact PI
Promoting Brain Resilience to Alzheimer's Neuropathology$761,022
R01 · FY2023 · AG · contact PI
Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders$779,858
R01 · FY2022 · AG · contact PI
Promoting Brain Resilience to Alzheimer's Neuropathology$769,735
R01 · FY2022 · AG · contact PI
Tau oligomer conformers and synaptic vulnerability/resilience in AD and related disorders$789,856
R01 · FY2021 · AG · contact PI
Promoting Brain Resilience to Alzheimer's Neuropathology$778,520
R01 · FY2021 · AG · contact PI
Promoting Brain Resilience to Alzheimer's Neuropathology$806,795
R01 · FY2020 · AG · contact PI
Summer Research Experiences in Neurological Dysfunction$105,434
R25 · FY2020 · NS · contact PI
Calcineurin Mediates the Synergistic Toxicity of Tau and Aβ Oligomers$3,532,750
RF1 · FY2019 · AG · contact PI
Mechanisms of Resilience to Alzheimer's Disease Neuropathology$776,425
R56 · FY2019 · AG · contact PI
Summer Research Experiences in Neurological Dysfunction$105,434
R25 · FY2019 · NS · contact PI
Calcineurin Mediates the Synergistic Toxicity of Tau and Aβ Oligomers$39,108
R01 · FY2019 · AG · contact PI
Summer Research Experiences in Neurological Dysfunction$105,434
R25 · FY2018 · NS · contact PI
Mechanisms of Resilience to Alzheimer's Disease Neuropathology$725,531
R56 · FY2017 · AG · contact PI
Mechanisms of resistance to cognitive decline in AD$310,000
R01 · FY2017 · AG · contact PI
Summer Research Experiences in Neurological Dysfunction$105,434
R25 · FY2017 · NS · contact PI
Mechanisms of resistance to cognitive decline in AD$310,000
R01 · FY2016 · AG · contact PI
Mechanisms of resistance to cognitive decline in AD$300,700
R01 · FY2015 · AG · contact PI
Mechanisms of resistance to cognitive decline in AD$310,000
R01 · FY2014 · AG · contact PI
Mechanisms of resistance to cognitive decline in AD$309,000
R01 · FY2013 · AG · contact PI
Calcineurin Inhibition for Reversing the Cognitive Effects of Amyloid$420,750
R01 · FY2010 · NS · contact PI
Calcineurin Inhibition for Reversing the Cognitive Effects of Amyloid$420,750
R01 · FY2009 · NS · contact PI
Role of Calcineuron in Abeta-Induced Behavioral Deficits$164,949
R21 · FY2007 · NS · contact PI
Role of Calcineurin in AB-Induced Behavioral Deficits$203,850
R21 · FY2006 · NS · contact PI
APOPTOTIC NEURAL SIGNALING PATHWAYS--AGING RELEVANCE$109,046
R29 · FY2001 · AG
APOPTOTIC NEURAL SIGNALING PATHWAYS--AGING RELEVANCE$104,933
R29 · FY2000 · AG